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Background: Prophylactic treatment with carbamazepine has been shown to reduce
the cerebral damage and neurologic deficit in ischemic conditions. A randomized con-
trolled study based on a rabbit model was designed to study the effect of carbamaze-
pine on a spinal cord ischemic reperfusion injury.
Methods: Thirty New Zealand rabbits were randomly assigned to 1 of the 2 groups
(n5 15 per group): group I (control group) and group II (carbamazepine group). Spi-
nal cord ischemia was induced by infrarenal aortic crossclamp for 25 minutes in both
groups. Functional evaluation with the Tarlov score during a 2-day observation period
and histopathologic assessment of the lumbar spinal cord were performed. Changes in
spinal cord morphology were observed with hematoxylin-eosin staining and electron
microscopy. Gray matter damage was assessed on the basis of the number of normal
neurons in the ventral horn.
Results: Diffuse destruction of gray matter with moderate to severe vacuolization and
essentially no normal ganglion cells was observed in the spinal cord of rabbits in the
control group, whereas specimens of rabbits assigned to the carbamazepine group
showed ganglion cells with normal nuclei and cytoplasm (P , .0001). Neurologic
impairment was significantly attenuated in the carbamazepine group compared with
the Tarlov scores of the control group (P , .0001 at day 2).
Conclusion: Carbamazepine may protect the spinal cord from ischemic reperfusion
injury that is associated with ameliorated neurologic and histopathologic results.
T
emporary or permanent interruption of the blood supply to the spinal cord may
cause spinal cord injury manifested by paraplegia, which continues to be
a major devastating and unpredictable complication after surgical repair of
descending and thoracoabdominal aortic aneurysms. Although the neurologic deficits
have significantly decreased in recent times with the progress of surgical adjuncts and
pharmacologic interventions, the incidence of paraplegia is still high at 6.6% to 8.3%
in patients with extent II thoracoabdominal aortic aneurysms.1,2 Evidently, long-
standing ischemia during aortic clamping and failure to restore flow to the spinal
cord will lead to infarction and irreversible neurologic deficits. Additional damage
to the spinal cord may occur during the period of reperfusion. This reperfusion injury
has been primarily attributed to biochemical causes, such as oxygen free radicals, leu-
kocytes, or other inflammatory mediators.3
Several efforts have been focused on solving this problem, which include surgical
techniques, pharmacologic intervention, and mechanical methods, such as hypother-
mia, cerebrospinal fluid drainage, and retrograde venous perfusion.4-7 The cellular
and molecular mechanisms of ischemic spinal cord injury are not fully understood.
Multiple studies have suggested that calcium overload, free radical production, plate-
let aggregation, neutrophil accumulation, and adhesion after ischemia may contribute
to neuronal ischemic spinal cord injury.8-12
There have been many reports on the methods of treatment or prevention of ische-
mic spinal cord injury,4-7 but to date, there is no scientifically established method.
Carbamazepine (CBZ) is an antiepileptic drug that has been extensively used in
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CBZ 5 carbamazepine
NMDA 5 N-methyl-d-aspartate
neurology in the treatment of epilepsies and trigeminal neu-
ralgia, and in psychiatry for the prophylactic treatment of af-
fective and schizoaffective psychosis. It has been shown that
preischemic treatment with CBZ tends to reduce the cerebral
damage and neurologic deficit.13 Schirrmacher and col-
leagues13 also suggested that CBZ reduces Ca12 currents
presumably by inhibiting L-type Ca12 channels in sensory
spinal ganglion cells. It also blocks N-methyl-d-aspartate
(NMDA) induced currents in cultured spinal cord neurons.13
NMDA antagonists have been proved to reduce spinal cord
injury after ischemia.14 This study was designed to investi-
gate the protective efficacy of CBZ on the neurologic and his-
topathologic outcomes of spinal cord ischemia caused by
aortic occlusion in rabbits.
Materials and Methods
Thirty New Zealand rabbits of either sex, weighing 2.5 to 3.5 kg,
were used in the experiments. The animal protocol was approved
by the Ethics Review Committee for Animal Experimentation of
Ankara University, Faculty of Veterinary.
As a previously described dose15 in rabbits, a single dose of
20 mg/kg/d of CBZ (Tegretol oral suspension, 100 mg/5 mL; No-
vartis Pharmaceuticals, Basel, Switzerland) was administered by
oral gavage with a 3-inch 18-gauge gavage needle to the study group
for 5 days before the experiment. During the study period, all ani-
mals received humane care in compliance with the Guide for the
Care and Use of Laboratory Animals from the Institute of Labora-
tory Animals, National Research Council (publication no. National
Institutes of Health 85-17).
Spinal Cord Ischemia
The spinal cord ischemia was induced according to the method pre-
viously described by Wakamatsu and colleagues.10 After an over-
night fast with unrestricted access to water, the rabbits were
premedicated with atropine sulfate (0.005 mg/kg, administered sub-
cutaneously) and anesthetized with intramuscularly administered
ketamine hydrochloride (40 mg/kg) and xylazine (10 mg/kg). Inter-
mittent intravenous readministration of one-quarter doses of the an-
esthetic agents was rendered to maintain an adequate level of
anesthesia and prevent the need for endotracheal intubation and me-
chanical ventilation. A pediatric facial mask in which oxygen gas
flowed at a rate of 200 mL/min was placed on each rabbit. The arte-
rial blood pressure was measured via a 24-gauge catheter inserted
into the right femoral artery, which was also used for drawing blood
samples. With the rabbits in the prone position, the abdomen was
opened via a vertical midline incision to expose the abdominal aorta.
The aorta and its branches were meticulously dissected from caudal
to the left renal artery. Heparin (150 U/kg-1) was given and spinal
cord ischemia was produced by occluding the abdominal aorta (cau-
dal to the renal arteries) with an arterial clamp for 25 minutes afterThe Journal of Thora previously established ideal ischemic time. After 25 minutes, the
clamp was removed, thus beginning reperfusion. After completion
of surgery, the aorta was detected to be intact, and the abdominal
wall was closed with 4-0 nylon suture in separate layers. The local
infiltration around the wound with 0.25% bupivacaine hydrochlo-
ride was applied for postoperative analgesia. The animals were in-
tramuscularly administered gentamicin (40,000 U) and allowed to
recover with free access to food and water. During the procedure,
lactated Ringer’s solution was infused via an ear vein. Arterial blood
pressure and heart beat were continuously monitored, body temper-
ature was continuously monitored with a flexible probe inserted 5
cm into the rectum, and core temperature was maintained at 38C
to 39C by heating lamps. Arterial blood was sampled for determi-
nation of blood gases and plasma glucose. The hemodynamic pa-
rameters were recorded 20 minutes before ischemia, during
ischemia, and 10 minutes after reperfusion.
Neurologic Assessment
Neurologic recovery was graded by an independent observer, using
a modified Tarlov scale:16 grade 0, no movement of the lower limbs;
grade 1, minimal movement; grade 2, good movement but unable to
stand; grade 3, able to stand and walk but unable to hop normally;
and grade 4, normal recovery.
Two days after clamping, transcardial 4% paraformaldehyde in
0.1 mol/L phosphate-buffered saline perfusion under (1 mL/100 g)
30% pentobarbital (65 mg/kg) terminal anesthesia method was
used for preserving the spinal cords. Laminectomy was performed
within 30 minutes after death, and the midlumbar segment of spinal
cord was harvested.
Histologic Study
Light microscopy. To see the histopathologic changes of the spi-
nal cord after ischemia, the spinal cords were removed and fixed in
10% formalin for 48 hours at room temperature. Samples were then
cut transversely at approximately the L4-L5 level, and after process-
ing with the conventional histotechnologic methods, they were em-
bedded in paraffin; 5-mm–thick sections were stained with the
hematoxylin-eosin stain and cresyl violet method for Nissl sub-
stance. The number of intact large motor neuron cells in the ventral
gray matter region was counted in 5 sections per animals. An ob-
server, who was unaware of animal group and neurologic outcome,
examined each slide (3100). Classification and quantification of an-
terior horn motor neurons were done in sections. Features consistent
with neuronal injury included vacuolization, eosinophilic cyto-
plasm, and pyknotic appearance. Cells containing Nissl substance
in the basophilic cytoplasm, euchromatin nucleus, and prominent
nucleoli were considered viable.
Electron microscopy. Samples to be observed for transmission
electron microscopy were fixed in 0.2 mol/L phosphate buffer con-
taining 2% (w/v) paraformaldehyde and 2.5% (v/v) glutaraldehyde
for 3 hours at 4C. They were washed in 0.1 mol/L phosphate buffer
and fixed with 1% osmium tetroxide for 2 hours as secondary fixa-
tion. After washing, they were embedded in Araldite 6005 and cut
with Leica Ultracut R (Leica Microsystems, Vienna, Austria) ultra-
microtome. Semi-thin sections (1 mm) were stained by toluidine
blue-Azur II to select a region of interest for the following proce-
dures, and thin sections (60–70 nm) were stained with uranyl acetate
and lead citrate. Theywere examined and photographed using a LEO
906 E TEM (80 kV; Carl Zeiss SMT AG, Oberkochen, Germany).acic and Cardiovascular Surgery c Volume 136, Number 4 1039
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Group sample sizes of 15 and 15 achieve 81% power to detect a dif-
ference of 1.0 of the neurologic scores between the null hypothesis
that both group means are 1.0 and the alternative hypothesis that the
mean of group 2 is 2.0 with estimated group standard deviations of
0.90 and 0.90 and a significance level (alpha) of 0.05 using a 2-sided
Mann–Whitney test, assuming that the actual distribution is normal.
The degree of association between variables was evaluated by
Spearman’s correlation coefficient. Comparisons between groups
for the continuous variables were evaluated by Student t test or
Mann–Whitney U test, where applicable. Bonferroni adjustment
was applied for multiple comparisons.
Results
Physiologic and Hemodynamic Parameters
Hemodynamic variables are shown in Table E1. There were
no statistical differences in the hemodynamic parameters of
the animals in both groups. There were also no differences
between the 2 groups regarding PAO2, PACO2, base excess,
and glucose levels (Table E2).
Neurologic Outcomes
The animals in both groups had normal motor function before
the study. An intermediate level of spinal cord ischemia in
a rabbit (ie, 20–21 minutes) will usually result in full return
of neurologic function after restoration of blood flow to the
spinal cord, and the rabbit will be able to hop normally and
show no functional change; however, this is often (71%) fol-
lowed by the onset of recurrent and progressive paraplegia
within 14 to 48 hours.17
For this reason, we Tarlov scored the animals 48 hours
after reperfusion and noted the final changes. After reperfu-
sion, although none of the animals reached a Tarlov score
of 2 in the control group, 2 animals reached a Tarlov score
of 3 and 5 animals reached a Tarlov score of 2 in the study
group (Figure E1). The mean scores were significantly higher
in the CBZ group (1.66 0.7 vs 0.46 0.5; P, .0001) (Table
E3). There was a significant negative correlation between the
Tarlov Score and the percentage of dead total neurons (r 5
20.627, P , .001).
Histopathologic Examination
Although there were no normal neuron cells in the control
group, the mean number of the normal neurons of CBZ group
was 57.6 6 79.3 (P 5 .0001). The mean numbers of the ne-
crotic motor neurons were higher in the control group without
statistical significance (113.8 6 16.3 vs 90.0 6 35.7; P 5
.061). After calculation of the percentage of necrotic cells in
bothgroups, this percentagewas significantlyhigher in the con-
trol group (100.06 0.0 vs 71.16 35.1; P, .001 (Table E3).
Representative topographic photomicrographs of sections
from the control group and CBZ group are shown in Figure 1,
A and B, respectively. In spinal cord sections from the control
group, all the ventral horn neurons of the spinal cord demon-
strated shrinkage of the cell body, pyknosis of the nucleus,1040 The Journal of Thoracic and Cardiovascular Surgery c Ocdisappearance of the nucleolus, and loss of Nissl substance,
with intense eosinophilia of the cytoplasm (red neuron)
(Figure 1, C). The loss of the Nissl substance in the cell
body (chromatolysis) was also detected with cresyl violet
stain (Figure 1, D). In the CBZ group, the number of normal
neurons between the necrotic neurons was high; this finding
was statistically significant (P, .0001). The normal neurons
were characterized by large perikarya with abundant Nissl
substance and large nuclei with prominent single nucleoli
(Figure 1, E and F).
In ultrastructural examinations of the groups, the control
group showed necrotic neurons with a pyknotic nucleus
and disappearance of the nucleolus, but in the CBZ group,
the ultrastructural appearance of the neurons was like that
of normal neurons (Figure 2).
Discussion
Spinal cord injury remains a serious problem after operations
on the descending and thoracoabdominal aorta. Despite var-
ious surgical and pharmacologic approaches to minimize the
risk of paraplegia, no methods have effectively prevented this
complication.1
The mechanism of motor neuronal cell death after spinal
cord ischemia and reperfusion has been explored through
molecular, cellular, and genetic aspects, but it has not been
identified.11 Some patients undergoing thoracoabdominal
aneurysm repair, with no neurologic deficit, develop de-
layed-onset paraplegia 1 to 5 days later. The cause of this lat-
ter phenomenon is poorly understood, but it has been
attributed to postoperative hypotension, embolization to the
anterior spinal artery, occlusion of a reimplanted intercostal
artery, or anterior spinal artery thrombosis.17 The precise
pathophysiology of this phenomenon, however, has not
been identified. The observation of such delayed neurologic
deficits suggests the presence of additional mechanisms of
spinal cord injury that might include cord edema in a confined
space, cytotoxic action from leukocytes or microglia, vaso-
constriction from arachidonic acid metabolites, and free-rad-
ical injury from metabolic by-products of ischemia.18-21
Evidence is gathering that a various combination of fac-
tors induce over-accumulation of intracellular calcium,
which triggers proteases, lipase, protein kinase C, nitric oxide
synthase, endonucleases, altered gene transcription, and re-
lease of free radicals, eventually producing neuronal injury
and death.4
Ouardouza and colleagues22 concluded that reducing
Ca21 import through reverse Na1/Ca21 exchange, reducing
influx through L-type Ca21 channels, and indirectly inhibit-
ing Ca21 release from the endoplasmic reticulum attenuated
spinal cord dorsal column ischemia in vitro. Pharmacologic
openers of mitochondrial triphosphate-sensitive potassium
(mitoKATP) channels (diazoxide) resulted in significant im-
provement in neurologic outcome in a model of spinal cord
ischemia by a preconditioning effect.23tober 2008
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PFigure 1. Histologic appearance of sec-
tions of spinal cord ventral horn in light
microscopy. Topographic photomicro-
graphs of sections in control group (A)
and CBZ group (B). C, Necrotic red neu-
rons with pyknotic nucleus and perivas-
cular edema in control group with
hematoxylin-eosin stain. D, Loss of
Nissl bodies is evident by cresyl violet
stain in control group. E, Intact neurons
and capillaries have normal appear-
ance in CBZ group with hematoxylin-
eosin stain. F, Euchromatin large nu-
cleus, prominent nucleolus (arrow),
and Nissl bodies (arrowhead) are
shown with cresyl violet stain in CBZ
group. Bar scale 5 50 nm. N, Neuron;
n, pyknotic nucleus; c, capillaries; pe,
perivascular edema.
Figure 2. Ultrastructural examination of
spinal cord ventral horn in electron mi-
croscopy. A, Necrotic neuron in control
group; pyknotic nucleus. Other organ-
elles could not be detected. B, Examina-
tion of viable neuron in CBZ group with
euchromatin nucleus and prominent nu-
cleolus (arrow). C, Normal ultrastruc-
ture of the spinal cord anterior horn
neuron. Bar scale 5 10 mm. N, Neuron;
n, pyknotic nucleus.The Journal of Thoracic and Cardiovascular Surgery c Volume 136, Number 4 1041
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CSPIn a recent study,24 both retrograde and systemic adeno-
sine A2A agonist therapies were effective in attenuating is-
chemic spinal cord injury. The findings of Crown and
Grau25 indicate that serotonergic systems normally protect
spinal cord plasticity from the deleterious effects of uncon-
trollable stimulation.
Glutamate is the major excitatory neurotransmitter in the
central nervous system of vertebrates. Under normal condi-
tions, neurons are exposed to physiologic concentrations of
glutamate in the course of excitatory neurotransmission.
Such exposure is not injurious.During ischemia, amassive re-
lease of glutamate into the extracellular space26 coupled with
a decreased capacity of metabolically impaired glia to trans-
port glutamate augments injury and facilitates neuronal death.
The study of Mills and colleagues4 was conducted to collect
the excitatory amino acids by microdialysis fibers inserted
close to the impact region of the spinal cord and effectively
decreased their levels in a rat model of spinal cord injury.
It has been shown that CBZ has all these aforementioned
properties: It inhibits Ca21 channels, enhances 4-aminopyri-
dine-sensitive potassium currents in cortical neurons, acts as
an antagonist of adenosine A1 receptors, attenuates cyclic
adenosine monophosphate production, induces the release
of serotonin, and inhibits the release of glutamate.21
CBZ also blocks NMDA-activated membrane currents in
cultured neurons in a dose-dependent fashion. The NMDA
receptor-activated channel, which is blocked at physiologic
concentrations of Mg21 at resting membrane potential, can
be activated by glutamate in depolarized neurons.27,28 There-
fore, the block of NMDA-evoked membrane currents in cul-
tured neurons may contribute to the clinical effectiveness of
CBZ.
With anoxia, ischemia, and mitochondrial dysfunction,
the primary factor detrimental to neurons is insufficient en-
ergy supply relative to their requirement. Accordingly, reduc-
tion of energy demand is a rational neuroprotective strategy.
Down-modulation of voltage-gated Na1-channels is another
effective way to reduce adenosine triphosphate demand be-
cause a large part of the energy consumed by nerve cells is
used for the maintenance and replenishment of ionic gradi-
ents (especially Na1 gradient) across the cellular membrane.
NS-7, a novel Na1/Ca21 channel blocker, protected the spi-
nal cord against ischemic insults by preventing neuron necro-
sis and apoptosis.29 CBZ also blocks neuronal Na1 channels
and has been shown to be cerebroprotective in various
models of cerebral ischemia. It provides significant protec-
tion from oxygen deprivation. These effects may be respon-
sible for the neuroprotective effects of CBZ even under
ischemic conditions.
We focused on the therapeutic benefits of CBZ for func-
tional recovery after spinal cord ischemia. There was signif-
icant improvement in the neurologic outcomes of rabbits that
received CBZ compared with the control group. The CBZ
group had higher Tarlov scores than the control animals.1042 The Journal of Thoracic and Cardiovascular Surgery c OcAlthough none of the animals in the control group were
able to stand, 2 animals in the CBZ group were able to stand
and walk. It was confirmed in the present study that both mo-
tor function scores and the percentage of normal neurons in
the anterior spinal cord at 48 hours in the CBZ group were
significantly higher than those in the control group.
Histologic examination confirmed the ability of CBZ to
limit neuronal degeneration and necrosis in the anterior
horn motor neurons. Histologic examination of the spinal
cords revealed less evidence of injury in the CBZ group,
whereas spinal cords from control animals had evidence of
extensive spinal cord injury with central gray matter necrosis,
perikaryal shrinkage, vacuolization of anterior horn motor
neurons, and Nissl substance dissolution. These morphologic
changes developed after ischemia and caused the physiologic
and clinical consequences observed after ischemic distur-
bance. The number of normal neurons at the anterior spinal
cord has direct relations with neurologic function, which
was manifested by a strong correlation between the final neu-
rologic outcomes and the number of normal neurons at the
anterior spinal cord.
Furthermore, previous studies showing that CBZ is more
effective under inflammatory conditions30 and that the phar-
macokinetic behavior of CBZ was not significantly altered in
the early phase of spinal cord ischemia15 strengthened our
motivation to investigate the efficacy of the drug in spinal
cord ischemia.
Ischemia-reperfusion injury may cause glutamate efflux
from energy-depleted astrocytes through multiple mecha-
nisms, including reversed glutamate transport and swelling-
evoked or Ca21-dependent release. Glutamate also might
spill into the white matter from the neighboring ischemic
gray matter. Ischemia-induced increases in extracellular glu-
tamate concentration could result in toxic activation of func-
tional AMPA (2-[aminomethyl]phenylacetic acid)/kainate
glutamate receptors on oligodendrocytes and astrocytes.
Competitive NMDA27 and AMPA/kainate glutamate recep-
tor antagonism has been an efficacious measure in spinal
cord ischemia.28 In view of the prominent role of NMDA re-
ceptor mechanism in gray matter injury, the possible neuro-
protective effects of NMDA antagonism of CBZ in spinal
cord ischemia on the blockade of glutamate receptors to re-
duce ischemia-induced spinal cord damage may have a lim-
ited therapeutic window.30 In the present study, CBZ was
tested in a pretreatment fashion. The effectiveness of CBZ
in a posttreatment fashion was not examined. We aimed to
explore preventive measures that may protect the spinal
cord from ischemic insult, and we preferred effective pre-
treatment to posttreatment.
Conclusions
Our study demonstrates that premedication with CBZ
may improve motor functional recovery after spinal cord
ischemia.tober 2008
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Figure E1. Scatter plot of the Tarlov score for each group. CBZ,
Carbamazepine.1043.e1 The Journal of Thoracic and Cardiovascular Surgery c October 2008
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Control group CBZ group
Mean 6 SD Median (IQR) Mean 6 SD Median (IQR) P
HRa 294.2 6 10.4 297.0 (10.0) 293.1 6 12 293.0 (10.75) .880
HRb 266.8 6 9.4 270.0 (4.0) 265.8 6 10.2 267.0 (8.5) .806
HRc 277.2 6 10.1 280.0 (15.0) 277.0 6 11.2 277.5 (15.0) .838
MAPa 84.6 6 2.7 85.0 (5.0) 84.5 6 2.1 84.0 (3.0) .941
MAPb 18.0 6 1.0 18.0 (2.0) 17.6 6 1.2 18.0 (3.0) .389
MAPc 83.8 6 3.1 84.0 (5.0) 84.0 6 2.3 83.0 (4.0) .845
Treca 39.1 6 0.3 39.1 (0.50) 39.1 6 0.3 39.0 (0.55) .910
Trecb 38.6 6 0.2 38.6 (0.50) 38.6 6 0.2 38.5 (0.53) .775
Trecc 38.9 6 0.2 39.0 (0.30) 39.0 6 0.2 39.0 (0.35) .578
CBZ, Carbamazepine; SD, standard deviation; IQR, interquartile range; HR, heart rate; MAP, mean arterial pressure; Trec, rectal temperature. a20 minutes
before ischemia. bDuring ischemia. c10 minutes after reperfusion.CS
P
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CSPTABLE E2. Physiologic parameters
Control group CBZ group
Mean 6 SD Median (IQR) Mean 6 SD Median (IQR) P
pHa 7.34 6 0.019 7.34 (0.03) 7.34 6 0.017 7.35 (0.03) .866
pHb 7.33 6 0.007 7.33 (0.01) 7.33 6 0.007 7.33 (0.01) .786
pHc 7.32 6 0.007 7.32 (0.01) 7.32 6 0.008 7.32 (0.02) .623
PCO2
a 38.0 6 3.0 39.0 (5.0) 38.0 6 2.9 38.0 (4.0) 1.000
PCO2
b 37.84 6 0.18 37.9 (0.30) 37.87 6 0.12 37.9 (0.20) .898
PCO2
c 37.73 6 0.18 37.8 (0.30) 37.76 6 0.12 37.7 (0.20) .932
PO2
a 412.8 6 45.0 417.0 (55.0) 420.8 6 44.2 427.0 (74.0) .627
PO2
b 411.5 6 6.55 413.0 (12.0) 415.4 6 4.81 417.0 (9.0) .076
PO2
c 413.9 6 6.00 415.0 (11.0) 417.7 6 5.6 419.0 (11.0) .090
Base excessa 22.55 6 0.51 22.70 (0.80) 22.50 6 0.56 22.50 (1.10) .771
Base excessb 22.89 6 0.09 22.90 (0.20) 22.88 6 0.09 22.90 (0.10) .723
Base excessc 22.69 6 0.09 22.70 (0.20) 22.68 6 0.09 22.70 (0.10) .723
Glucosea 128.4 6 8.0 128.0 (11.0) 128.6 6 6.4 128.0 (6.0) .941
Glucoseb 130.9 6 9.12 130.0 (8.0) 131.3 6 9.97 130.0 (10.0) .739
Glucosec 140.9 6 8.92 140.0 (8.0) 140.7 6 9.94 140.0 (10.0) .939
CBZ, Carbamazepine; SD, standard deviation; IQR, interquartile range. a20 minutes before ischemia. bDuring ischemia. c10 minutes after reperfusion.1043.e3 The Journal of Thoracic and Cardiovascular Surgery c October 2008
Sırlak et al Cardiopulmonary Support and PhysiologyTABLE E3. Neurologic parameters
Control group CBZ group
Mean 6 SD Median (IQR) Mean 6 SD Median (IQR) P
Normal neuron (n) 0.0 6 0.0 0.0 (0.0) 57.6 6 79.3 8.0 (143.0) ,.001
Necrotic neuron (n) 113.8 6 16.3 105.0 (26.0) 90.0 6 35.7 101.0 (55.0) .061
% necrotic cells 100.0 6 0.0 100.0 (0.0) 71.1 6 35.1 91.8 (66.0) ,.001
Tarlov score 0.4 6 0.5 0.0 (1.0) 1.6 6 0.7 1.0 (1.0) ,.001
CBZ, Carbamazepine; SD, standard deviation; IQR, interquartile range.CS
P
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